건선 치료용 한약제제에 대한 임상시험 가이드라인 설명 및 제언
Explanation and Elaboration of the Clinical Trial Guidelines for Psoriasis Using Herbal Medicine
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objectives : We report on the contents and reviews of the guidelines for clinical trials of herbal medicine for psoriasis. Methods : After reviewing the existing reports, the guidelines were drafted by the writing committee on guidelines for Korean medicine clinical trial center in Kyung Hee university Korean medicine hospital. Since then, the guidelines have been consulted by the experts in diseases, clinical trials and pharmaceuticals. In addition, the guidelines have been certified by the Korean medicine clinical trial center association and Korean Medicine Ophthalmology & Otolaryngology & Dermatology Society. Results : The guidelines for clinical trials are divided into 8 categories: (1) general contents, (2) evaluation standards of effectiveness, (3) outcome valuables, (4) selection of study participants, (5) designs of clinical trials, (6) safety evaluations, (7) combination therapies in psoriasis treatment and (8) Korean medical considerations. Conclusions : There are 3 major contents for discussion: (1) obscurity of Korean medical considerations to differentiate from existing guidelines, (2) the absence of Korean version of PASI and DLQI, which are validity parameters and (3) realistic institutional problem using the herbal medicine.
Abstract
Objectives : We report on the contents and reviews of the guidelines for clinical trials of herbal medicine for psoriasis. Methods : After reviewing the existing reports, the guidelines were drafted by the writing committee on guidelines for Korean medicine clinical trial center in Kyung Hee university Korean medicine hospital. Since then, the guidelines have been consulted by the experts in diseases, clinical trials and pharmaceuticals. In addition, the guidelines have been certified by the Korean medicine clinical trial center association and Korean Medicine Ophthalmology & Otolaryngology & Dermatology Society. Results : The guidelines for clinical trials are divided into 8 categories: (1) general contents, (2) evaluation standards of effectiveness, (3) outcome valuables, (4) selection of study participants, (5) designs of clinical trials, (6) safety evaluations, (7) combination therapies in psoriasis treatment and (8) Korean medical considerations. Conclusions : There are 3 major contents for discussion: (1) obscurity of Korean medical considerations to differentiate from existing guidelines, (2) the absence of Korean version of PASI and DLQI, which are validity parameters and (3) realistic institutional problem using the herbal medicine.
참고문헌 (13)
- Kang H, "Textbook of Dermatology", pp.299~ (2014), Medbook
- Christophers E, "Psoriasis--epidemiology and clinical spectrum", Clin Exp Dermatol, 26(4), pp.314~320 (2001)[DOI]
- Boehncke WH, "Psoriasis", Lancet, 386(9997), pp.983~994 (2015)[DOI]
- 강세현, "건선 한약제제 임상시험 가이드라인 개발을 위한 관련 국내외 가이드라인과 기존 건선치료 한약제제 연구와의 비교", 한방안이비인후피부과학회지, 29(2), pp.12~32 (2016), 대한한방안이비인후피부과학회[DOI]
- Bozek A, "The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment", Adv Clin Exp Med, 26(5), pp.853~ (2017)
- He J, "Quality assessment of reporting of randomization, allocation, concealment and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews", Trials, 12, pp.122~ (2011)[DOI]
- Cheng CW, "CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation and Elaboration", Ann Intern Med, 167(2), pp.112~ (2017)[DOI]
- Preferred Reporting Items for Development of Clinical Practice Guideline in Korean Medicine, "Korea Institute of Oriental Medicine", Elsevier Korea L.L.C, 12~ (2015)
- Jeong SY, "The Clinical trial Guideline of the new medicine and Traditional chinese medicine", Chinese Medicine and science press, 1, pp.299~302 (2002)
- Seo HS, "Text of Traditional Korean Dermatology & Surgery", pp.381~386 (2007), SunWo
- ". Notice of Ministry of Health and Welfare" (2018)[URL]
- 성영희, "Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep", Journal of Korean Medical Science, 33(2), pp.54~67 (2018), 대한의학회
- Youn SW, "The Assessment of Psoriasis Severity: PASI, BSA, DLQI", J Korean Soc for Psoriasis, 10(1), pp.11~14 (2013)